title: Intravenous immunoglobulin in two children with Guillain-Barré syndrome.
abstract: Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.
authors: Department of Paediatrics, University of Brescia, Italy.
authors: L D
authors: LD
authors: Notarangelo
authors: M
authors: M
authors: Duse
authors: S
authors: S
authors: Tiberti
authors: B
authors: B
authors: Guarneri
authors: A
authors: A
authors: Brunori
authors: A
authors: A
authors: Negrini
authors: A G
authors: AG
authors: Ugazio
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D011129:Polyradiculoneuropathy / Q000628:therapy*; D012008:Recurrence
chemical_list: D016756:Immunoglobulins, Intravenous